von Gruenigen, Vivian E <br/><br/>
Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies:  a phase I study.  [electronic resource] 

 -  Anti-cancer drugs  Aug 2012 
 - 724-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e32835396d4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia--chemically induced<br/>Cohort Studies<br/>Diarrhea--chemically induced<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Ovarian Neoplasms--drug therapy<br/>Topoisomerase I Inhibitors--therapeutic use<br/>Topotecan--therapeutic use<br/>Uterine Neoplasms--drug therapy